I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness/fitness myths. In my free time I enjoy ...

Starting your investing journey can feel overwhelming, but it doesn’t have to be. Today’s best online brokers for beginners are designed to simplify the process from opening your first account to ...

New York City Tourism + Conventions has revealed the start of reservations for NYC Winter Outing 2026. The program runs from January 20 through February 12, offering savings on experiences across all ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

Evie Carrick is a writer and editor who’s lived in five countries and visited well over 50. She now splits her time between Colorado and Paris, ensuring she doesn't have to live without skiing or L'As ...

The 2025 NFL season is one of the more top-heavy seasons in recent years. This season has 19 of the league's 32 teams still in Super Bowl contention, the most with three weeks to play since 2005 (18 ...

If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. I’ve been playing piano since I was four years old and I ...

The best short-term CD rates can help you reach your savings goals faster Written By Written by Staff Senior Editor, Buy Side Miranda Marquit is a staff senior personal finance editor for Buy Side.

(NEXSTAR) – The World Health Organization has issued new guidance on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro, and Zepbound, to treat the “major global health challenge” of ...

I've been testing PC and mobile software for more than 20 years, focusing on photo and video editing, operating systems, and web browsers. Prior to my current role, I covered software and apps for ...

Netflix announced a 10-for-1 stock split. The fundamentals of the company stay the same, but the pricey shares will be more accessible to retail investors. The stock is currently one of 10 names in ...